These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 25108409

  • 1. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
    Ibrahim TR, Abdel-Raouf SM.
    Pathol Oncol Res; 2015 Apr; 21(2):379-87. PubMed ID: 25108409
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
    Fujiwara M, Kwok S, Yano H, Pai RK.
    Cancer Cytopathol; 2012 Aug 25; 120(4):230-7. PubMed ID: 22434791
    [Abstract] [Full Text] [Related]

  • 4. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
    McKnight R, Nassar A, Cohen C, Siddiqui MT.
    Cancer Cytopathol; 2012 Aug 25; 120(4):223-9. PubMed ID: 22298472
    [Abstract] [Full Text] [Related]

  • 5. Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology.
    Zaakook M, Ayoub M, Sinna EA, El-Sheikh S.
    J Egypt Natl Canc Inst; 2013 Dec 25; 25(4):173-80. PubMed ID: 24207089
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic accuracy of glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours.
    Majeed S, Mushtaq S, Azam M, Akhtar N, Hussain M, Loya A.
    J Pak Med Assoc; 2018 Jul 25; 68(7):1029-1031. PubMed ID: 30317296
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
    Li J, Wei L.
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr 25; 43(4):246-50. PubMed ID: 24915815
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
    Tremosini S, Forner A, Boix L, Vilana R, Bianchi L, Reig M, Rimola J, Rodríguez-Lope C, Ayuso C, Solé M, Bruix J.
    Gut; 2012 Oct 25; 61(10):1481-7. PubMed ID: 22287594
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma.
    Fatima N, Cohen C, Siddiqui MT.
    Acta Cytol; 2014 Oct 25; 58(1):83-8. PubMed ID: 24281232
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.
    Yao S, Zhang J, Chen H, Sheng Y, Zhang X, Liu Z, Zhang C.
    J Histochem Cytochem; 2013 Sep 25; 61(9):639-48. PubMed ID: 23686365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.